QOL Assessment in Chronic Hepatitis C Patients Receiving Ledipasvir/ Sofosbuvir or Simeprevir/Peginterferon/Ribavirin in Clinical Practice 論文 Yuka Aimono・Noriko Kohyama・Toshiro Kamoshida・Toshinori Yamamoto・Mari Kogo ·2019-10-31 ·『YAKUGAKU ZASSHI』 139(11) pp. 1427-1434 doi:10.1248/yakushi.19-00019